Endocrine Abstracts

Objective: Increasing obesity rates are causing a surge in non-alcoholic fatty liver disease (NAFLD) prevalence which may progress further to non-alcoholic steatohepatitis (NASH) to cirrhosis. The utility of Fibroscan was shown in stratifying risk for significant liver disease in patients with obesity but it has a limited availability. The aim of the study was to compare the accuracy of Fibrosis-4 (FIB-4)) score to diagnose advanced fibrosis in overweight and obesity patients....